文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症监护病房获得性衰弱风险预测模型的建立与验证

[Establishment and validation of a risk prediction model for intensive care unit-acquired weakness].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论基于SIRS、APACHEⅡ评分、机械通气时长和血乳酸的ICU-AW风险预测模型内部验证AUC 0.888,外部验证AUC 0.853,可早期识别高危患者。

该研究采用便利抽样法纳入2019年7月至2020年6月嘉兴市第一医院ICU的231例患者作为建模组,按是否发生ICU-AW分为ICU-AW组55例和非ICU-AW组176例,比较两组临床资料,用Logistic回归分析ICU-AW危险因素并构建风险预测模型,计算ROC曲线下面积(AUC)检验预测效果;同时收集2020年7月至10月收治的60例符合标准患者验证模型。结果显示,ICU-AW组男性比例、SIRS、脓毒症、制动和使用神经肌肉阻滞剂比例均高于非ICU-AW组,APACHEⅡ评分、血乳酸水平、机械通气时长和住院时长均增加(均P<0.05)。SIRS、APACHEⅡ评分、机械通气时长和血乳酸被纳入构建风险预测模型(OR值分别为4.835、1.083、1.210、1.790,P值分别为0.018、0.013、0.015、0.013),模型方程:P=exp[-5.207+(1.576×SIRS)+(0.079×APACHEⅡ)+(0.191×机械通气时长)+(0.582×血乳酸)]。内部验证校准曲线位于理想曲线上方,AUC=0.888(95%CI 0.839-0.938),cut-off值为0.166时灵敏度89.1%、特异度75.6%、最大指数0.649;外部验证校准曲线位于理想曲线上方,AUC=0.853(95%CI 0.753-0.953),对应预测风险值cut-off值为0.

要点

  • 建模组231例中ICU-AW组55例、非ICU-AW组176例;ICU-AW组男性61.8%(34/55)vs 非ICU-AW组44.3%(78/176),P<0.05。
  • ICU-AW组SIRS 30.9%(17/55)vs 3.4%(6/176)、脓毒症12.7%(7/55)vs 2.3%(4/176)、制动72.7%(40/55)vs 39.2%(69/176)、使用神经肌肉阻滞剂50.9%(28/55)vs 14.2%(25/176),均P<0.05。
  • ICU-AW组APACHEⅡ评分18(15,24)vs 12(8,17)、血乳酸2(1,2)mmol/L vs 1(1,2)mmol/L、机械通气时长7(4,12)天 vs 2(2,5)天、住院时长10(6,16)天 vs 5(3,9)天,均P<0.05。
  • Logistic回归显示SIRS(OR 4.835,P=0.018)、APACHEⅡ评分(OR 1.083,P=0.013)、机械通气时长(OR 1.210,P=0.015)、血乳酸(OR 1.790,P=0.013)为ICU-AW独立危险因素。
  • 模型内部验证AUC=0.888(95%CI 0.839-0.938),cut-off 0.166时灵敏度89.1%、特异度75.6%;外部验证AUC=0.853(95%CI 0.753-0.953),cut-off 0.367时灵敏度68.8%、特异度86.4%。

适用人群与场景

  • 建模组:2019年7月至2020年6月嘉兴市第一医院ICU收治的符合纳入标准的231例患者,按是否发生ICU-AW分为ICU-AW组55例和非ICU-AW组176例。
  • 验证组:2020年7月至10月收治的符合标准的60例ICU患者。

诊断标准与关键阈值

  • 诊断标准:原文未明确列出ICU-AW的具体诊断标准,仅依据患者是否发生ICU-AW进行分组。
  • 模型预测阈值:内部验证cut-off值为0.166,外部验证对应预测风险值cut-off值为0.367。

研究设计与关键结果

  • 研究类型:风险预测模型建立与验证研究;建模组231例(ICU-AW组55例,非ICU-AW组176例),外部验证组60例。
  • ICU-AW组较非ICU-AW组:男性61.8%(34/55)vs 44.3%(78/176),SIRS 30.9%(17/55)vs 3.4%(6/176),脓毒症12.7%(7/55)vs 2.3%(4/176),制动72.7%(40/55)vs 39.2%(69/176),使用神经肌肉阻滞剂50.9%(28/55)vs 14.2%(25/176),均P<0.05。
  • ICU-AW组较非ICU-AW组:APACHEⅡ评分18(15,24)vs 12(8,17),血乳酸2(1,2)mmol/L vs 1(1,2)mmol/L,机械通气时长7(4,12)天 vs 2(2,5)天,住院时长10(6,16)天 vs 5(3,9)天,均P<0.05。
  • 多因素Logistic回归:SIRS OR=4.835(P=0.018),APACHEⅡ评分OR=1.083(P=0.013),机械通气时长OR=1.210(P=0.015),血乳酸OR=1.790(P=0.013)。
  • 模型方程:P=exp[-5.207+(1.576×SIRS)+(0.079×APACHEⅡ评分)+(0.191×机械通气时长)+(0.582×血乳酸)]。
  • 内部验证:校准曲线位于理想曲线上方,AUC=0.888(95%CI 0.839-0.938);cut-off值0.166时,灵敏度89.1%,特异度75.6%,最大指数0.649。
  • 外部验证:校准曲线位于理想曲线上方,AUC=0.853(95%CI 0.753-0.953);对应预测风险值cut-off值0.367时,灵敏度68.8%,特异度86.4%,最大近似指数0.552。

证据类型、等级与局限

  • 证据类型:单中心风险预测模型建立与验证研究(建模组与外部验证组来自同一医院不同时间段)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本研究构建的ICU-AW风险预测模型具有良好一致性和预测效能,可为医务人员早期识别ICU-AW高危人群并提供针对性干预提供参考。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the risk factors of intensive care unit-acquired weakness (ICU-AW), and to establishment and verify its risk prediction model.

METHODS: A modeling group of 231 patients who met the inclusion criteria and were admitted to the intensive care unit (ICU) of the First Hospital of Jiaxing from July 2019 to June 2020 was collected by convenience sampling method. According to whether they developed ICU-AW, they were divided into ICU-AW group (55 cases) and non ICU-AW group (176 cases). The clinical data were collected concerning patients' individual information, disease-related factors, treatment-related factors and laboratory indicators, and the differences of the above indexes between two groups were compared. Logistic regression was used to analyze the ICU-AW risk factors and a risk prediction model was constructed. Calculate the area under ROC curve (AUC) to test the prediction effect of the model. At the same time, 60 patients who admitted to ICU from July to October 2020 and met the standards were collected to verify the model.

RESULTS: Compared with non ICU-AW group, there were more males in ICU-AW group [61.8% (34/55) vs. 44.3% (78/176), P < 0.05], with higher levels of systemic inflammatory response syndrome (SIRS), sepsis, immobilization and the use of neuromuscular blockers [SIRS: 30.9% (17/55) vs. 3.4% (6/176), sepsis: 12.7% (7/55) vs. 2.3% (4/176), immobilization: 72.7% (40/55) vs. 39.2% (69/176), the use of neuromuscular blockers: 50.9% (28/55) vs. 14.2% (25/176), all P < 0.05], and acute physiology and chronic health evaluation II (APACHE II) score, blood lactic acid level and duration of mechanical ventilation, length of hospital stay were all increased [APACHE II score: 18 (15, 24) vs. 12 (8, 17), blood lactic acid (mmol/L): 2 (1, 2) vs. 1 (1, 2), duration of mechanical ventilation (days): 7 (4, 12) vs. 2 (2, 5), length of hospital stay (days): 10 (6, 16) vs. 5 (3, 9), all P < 0.05]. SIRS, APACHE II score, duration of mechanical ventilation and blood lactic acid were included to construct a risk prediction model [odds ratio (OR) values were 4.835, 1.083, 1.210, 1.790, P values were 0.018, 0.013, 0.015, 0.013]. The model equation was P = exp [-5.207+(1.576×SIRS)+(0.079×APACHE II)+(0.191×duration of mechanical ventilation)+(0.582×blood lactic acid)]. Internal verification: Calibration diagram showed the calibration curve above the ideal curve, AUC = 0.888, 95% confidence interval (95%CI) was 0.839-0.938; when the cut-off value was 0.166, the sensitivity was 89.1%, the specificity was 75.6%, and the maximum index was 0.649. External verification: Calibration diagram showed that the calibration curve was above the ideal curve, and the plotted AUC = 0.853, 95%CI was 0.753-0.953. When the cut-off value of the corresponding predictive risk value was 0.367, the sensitivity was 68.8%, the specificity was 86.4%, and the maximum approximate index was 0.552.

CONCLUSIONS: The risk prediction model of ICU-AW constructed in this study has good consistency and prediction efficiency, which can provide reference for medical personnel to identify high-risk groups of ICU-AW patients in the early stage and provide targeted interventions in advance.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang L, Lyu H, Shen Y, et al. [Establishment and validation of a risk prediction model for intensive care unit-acquired weakness]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 35131018. doi:10.3760/cma.j.cn121430-20210513-00707

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。